Collectively, these findings demonstrated that the PI3K/AKT signaling pathway is highly important for preventing obesity‐induced inflammation and IR and could be a potential therapeutic target for treating obesity and obesity‐related metabolic disorders. The gene discussed is AKT1; the disease is obesity disorder.